Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
entrez:
24
5
2020
pubmed:
24
5
2020
medline:
17
6
2020
Statut:
ppublish
Résumé
Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction. Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease. Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction. Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling. The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia. High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins.
Identifiants
pubmed: 32443324
doi: 10.1097/MD.0000000000020129
pii: 00005792-202005150-00040
pmc: PMC7254568
doi:
Substances chimiques
Antiparkinson Agents
0
Trihexyphenidyl
6RC5V8B7PO
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20129Références
Ugeskr Laeger. 2000 Mar 6;162(10):1366-70
pubmed: 10745673
J Am Soc Nephrol. 2001 Dec;12(12):2860-70
pubmed: 11729259
Mov Disord. 1989;4(3):202-12
pubmed: 2779591
Med Clin North Am. 1993 Jan;77(1):185-202
pubmed: 8093494
Curr Clin Top Infect Dis. 1991;11:35-51
pubmed: 1651090
Eur J Endocrinol. 2010 Jun;162 Suppl 1:S5-12
pubmed: 20164214
Therapie. 2006 Nov-Dec;61(6):537-9
pubmed: 17348612
BMJ Case Rep. 2013 May 22;2013:
pubmed: 23704432
Drug Intell Clin Pharm. 1986 Oct;20(10):786-7
pubmed: 3769769
Ann Pharmacother. 2005 Nov;39(11):1940-2
pubmed: 16174785
Minerva Psichiatr. 1994 Dec;35(4):199-219
pubmed: 7861943
J Nerv Ment Dis. 1994 Mar;182(3):168-73
pubmed: 7906709
Ugeskr Laeger. 1967 Nov 9;129(45):1511-2
pubmed: 5594302
Nephron Clin Pract. 2011;119(1):c62-73; discussion c73
pubmed: 21677440
Ann Endocrinol (Paris). 2011 Dec;72(6):500-12
pubmed: 22119069
J Endocrinol Invest. 2010 Oct;33(9):671-82
pubmed: 20935451
Dan Med Bull. 1966 Nov;13(8):204
pubmed: 5978771
N Engl J Med. 2007 May 17;356(20):2064-72
pubmed: 17507705